Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_assertion type Assertion NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_head.
- NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_provenance.
- NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_assertion evidence source_evidence_literature NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_provenance.
- NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_assertion SIO_000772 20628863 NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_provenance.
- NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_assertion wasDerivedFrom befree-20150227 NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_provenance.
- NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_assertion wasGeneratedBy ECO_0000203 NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_provenance.